Trials / Completed
CompletedNCT04644640
Telerehabilitation Following Meniscectomy
Telerehabilitation Following Meniscectomy: A Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Telerehabilitation is a form of tele-treatment in which rehabilitation services are dispensed at patients' home utilizing video telecommunication services with real-time synchronous exchange of information. Since telerehabilitation was found to be equally effective as conventional therapy, it was being practiced even before the COVID times, however it was truly valuable during the lockdown. The advantages of telerehabilitation include reducing unnecessary travel to the hospital and person to person contact while maintaining social distancing. While some of the patients are truly staying at remote areas, others are unable to manage travel in the lockdown period. Telemedicine offers the opportunity to deliver rehabilitative services in the patients' home, closing geographic, physical, and motivational gaps. Punctuality on either side is also assured since the travel times are saved on both the ends. The purpose of the proposed study is to evaluate telerehabilitation vs in-person rehabilitation following Meniscectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Telerehabilitation Therapy | Rehabilitation services will be dispensed at patients' home utilizing video telecommunication services with real-time synchronous exchange of information - range of motion exercises for the knee, proprioception and balance training |
| OTHER | In-person Rehabilitation Therapy | Range of motion exercises for the knee, proprioception and balance training |
Timeline
- Start date
- 2020-11-11
- Primary completion
- 2021-08-30
- Completion
- 2023-04-01
- First posted
- 2020-11-25
- Last updated
- 2023-05-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04644640. Inclusion in this directory is not an endorsement.